INSMED INC (INSM) Stock Price & Overview
NASDAQ:INSM • US4576693075
Current stock price
The current stock price of INSM is 160.18 USD. Today INSM is down by -1.75%. In the past month the price increased by 11.35%. In the past year, price increased by 133.6%.
INSM Key Statistics
- Market Cap
- 34.527B
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -6.41
- Dividend Yield
- N/A
INSM Stock Performance
INSM Stock Chart
INSM Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to INSM. When comparing the yearly performance of all stocks, INSM is one of the better performing stocks in the market, outperforming 92.06% of all stocks.
INSM Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to INSM. While INSM seems to be doing ok healthwise, there are quite some concerns on its profitability.
INSM Earnings
On January 9, 2026 INSM reported an EPS of -1.54 and a revenue of 263.84M. The company missed EPS expectations (-16.99% surprise) and beat revenue expectations (50.91% surprise).
INSM Forecast & Estimates
26 analysts have analysed INSM and the average price target is 215.19 USD. This implies a price increase of 34.34% is expected in the next year compared to the current price of 160.18.
For the next year, analysts expect an EPS growth of 54.28% and a revenue growth 220.75% for INSM
INSM Groups
Sector & Classification
INSM Financial Highlights
Over the last trailing twelve months INSM reported a non-GAAP Earnings per Share(EPS) of -6.41. The EPS decreased by -14.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -56.38% | ||
| ROE | -172.78% | ||
| Debt/Equity | 0.98 |
INSM Ownership
INSM Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.26 | 364.897B | ||
| AMGN | AMGEN INC | 15.33 | 183.284B | ||
| GILD | GILEAD SCIENCES INC | 16.01 | 172.309B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.9 | 109.705B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.59 | 80.376B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 43.86 | 42.375B | ||
| NTRA | NATERA INC | N/A | 29.66B | ||
| BIIB | BIOGEN INC | 11.19 | 25.773B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.48 | 24.795B | ||
| MRNA | MODERNA INC | N/A | 19.79B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.082B | ||
| INCY | INCYTE CORP | 12.52 | 18.645B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About INSM
Company Profile
The company is headquartered in Bridgewater, New Jersey and currently employs 1,664 full-time employees.
Company Info
IPO: 1991-02-15
INSMED INC
700 Us Highway 202/206
Bridgewater NEW JERSEY 08807 US
CEO: William H. Lewis
Employees: 1664
Phone: 19089779900
INSMED INC / INSM FAQ
Can you describe the business of INSMED INC?
The company is headquartered in Bridgewater, New Jersey and currently employs 1,664 full-time employees.
Can you provide the latest stock price for INSMED INC?
The current stock price of INSM is 160.18 USD. The price decreased by -1.75% in the last trading session.
What is the dividend status of INSMED INC?
INSM does not pay a dividend.
What is the ChartMill technical and fundamental rating of INSM stock?
INSM has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Which stock exchange lists INSM stock?
INSM stock is listed on the Nasdaq exchange.
Is INSMED INC (INSM) expected to grow?
The Revenue of INSMED INC (INSM) is expected to grow by 220.75% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the market capitalization of INSM stock?
INSMED INC (INSM) has a market capitalization of 34.53B USD. This makes INSM a Large Cap stock.